Avadel Pharmaceuticals Stock Forecast - Simple Moving Average

AVDL Stock  USD 11.22  0.44  3.77%   
The Simple Moving Average forecasted value of Avadel Pharmaceuticals PLC on the next trading day is expected to be 11.22 with a mean absolute deviation of 0.43 and the sum of the absolute errors of 25.09. Avadel Stock Forecast is based on your current time horizon. Although Avadel Pharmaceuticals' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Avadel Pharmaceuticals' systematic risk associated with finding meaningful patterns of Avadel Pharmaceuticals fundamentals over time.
  
Fixed Asset Turnover is expected to rise to 8.17 this year, although the value of Inventory Turnover will most likely fall to 0.09. . Common Stock Shares Outstanding is expected to rise to about 84.2 M this year, although the value of Net Loss is projected to rise to (117.5 M).
A two period moving average forecast for Avadel Pharmaceuticals is based on an daily price series in which the stock price on a given day is replaced by the mean of that price and the preceding price. This model is best suited to price patterns experiencing average volatility.

Avadel Pharmaceuticals Simple Moving Average Price Forecast For the 27th of November

Given 90 days horizon, the Simple Moving Average forecasted value of Avadel Pharmaceuticals PLC on the next trading day is expected to be 11.22 with a mean absolute deviation of 0.43, mean absolute percentage error of 0.53, and the sum of the absolute errors of 25.09.
Please note that although there have been many attempts to predict Avadel Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Avadel Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Avadel Pharmaceuticals Stock Forecast Pattern

Backtest Avadel PharmaceuticalsAvadel Pharmaceuticals Price PredictionBuy or Sell Advice 

Avadel Pharmaceuticals Forecasted Value

In the context of forecasting Avadel Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Avadel Pharmaceuticals' downside and upside margins for the forecasting period are 6.91 and 15.53, respectively. We have considered Avadel Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
11.22
11.22
Expected Value
15.53
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Avadel Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Avadel Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria113.7961
BiasArithmetic mean of the errors 0.0912
MADMean absolute deviation0.4253
MAPEMean absolute percentage error0.0324
SAESum of the absolute errors25.09
The simple moving average model is conceptually a linear regression of the current value of Avadel Pharmaceuticals PLC price series against current and previous (unobserved) value of Avadel Pharmaceuticals. In time series analysis, the simple moving-average model is a very common approach for modeling univariate price series models including forecasting prices into the future

Predictive Modules for Avadel Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Avadel Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Avadel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
7.0411.3515.66
Details
Intrinsic
Valuation
LowRealHigh
8.6312.9417.25
Details
10 Analysts
Consensus
LowTargetHigh
18.1019.8922.08
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.15-0.12-0.02
Details

Other Forecasting Options for Avadel Pharmaceuticals

For every potential investor in Avadel, whether a beginner or expert, Avadel Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Avadel Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Avadel. Basic forecasting techniques help filter out the noise by identifying Avadel Pharmaceuticals' price trends.

Avadel Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avadel Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Avadel Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Avadel Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Avadel Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Avadel Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Avadel Pharmaceuticals' current price.

Avadel Pharmaceuticals Market Strength Events

Market strength indicators help investors to evaluate how Avadel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Avadel Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Avadel Pharmaceuticals stock market strength indicators, traders can identify Avadel Pharmaceuticals PLC entry and exit signals to maximize returns.

Avadel Pharmaceuticals Risk Indicators

The analysis of Avadel Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Avadel Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting avadel stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Avadel Pharmaceuticals is a strong investment it is important to analyze Avadel Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Avadel Pharmaceuticals' future performance. For an informed investment choice regarding Avadel Stock, refer to the following important reports:
Check out Historical Fundamental Analysis of Avadel Pharmaceuticals to cross-verify your projections.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.09)
Revenue Per Share
1.036
Quarterly Revenue Growth
26.743
Return On Assets
(0.34)
Return On Equity
(1.00)
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.